The U.S. Food and Drug Administration has put on hold a trial of Novavax's COVID-influenza and its standalone flu vaccines ...
The Food and Drug Administration put clinical holds on Novavax's COVID-19 and flu combination vaccine and its standalone flu ...
Novavax said federal regulators put a clinical hold on its application for a combination Covid-19 and influenza vaccine and ...
Novavax shares tumbled after the Food and Drug Administration put a clinical hold on its testing applications for a combined ...
Novavax Inc.’s stock tumbled 16% early Wednesday after the company said the FDA has placed a clinical hold on its ...
The so-called clinical hold is due to a single report of nerve damage in a patient who received the combination shot in a ...
NVAX's COVID-19-flu combination and stand-alone flu vaccines have been placed on hold after a study participant who took the ...
The regulator placed a clinical hold on its Covid-19-influenza combination vaccine after one person reported nerve damage.
How bad is this news for Novavax? Let's find out. Image source: Getty Images.
Novavax’s plans for growth outside of its COVID program have been thrown into chaos after the FDA put the biooharma's flu ...
The hold, which was made in response to a serious adverse event report, could impact the company’s plans to start a Phase 3 ...
Novavax shares plummet 30% as FDA places clinical hold on COVID-19 and influenza combination vaccine due to serious adverse ...